Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet

Journal of Alzheimer's Disease

Volumn 22, Issue 4, 2010, Pages 1289-1303

  Chen, Xuesong ^a   Wagener, John F ^a   Morgan, Daniel H ^a   Hui, Liang ^a   Ghribi, Othman ^a   Geiger, Jonathan D ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Acid phosphatase; amyloid protein; cathepsin D; cholesterol; endosomes; lysosomes; olfactory bulb; synaptophysin; tau proteins

Indexed keywords

ACID PHOSPHATASE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN B; CATHEPSIN D; CHOLESTEROL; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; SYNAPTOPHYSIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL STRUCTURE; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYSOSOME; MALE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSYCHOLOGIC ASSESSMENT;

EID: 79751512757     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101323     Document Type: Article

References (98)

1. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403. (Pubitemid 44108123)
2. Hardy J (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 110, 1129-1134.
3. Seabrook GR, Ray WJ, Shearman M, Hutton M (2007) Beyond amyloid: the next generation of Alzheimer's disease therapeutics. Mol Interv 7, 261-270. (Pubitemid 47607486)
4. Sparks DL, Martin TA, Gross DR, Hunsaker JC, 3rd (2000) Link between heart disease, cholesterol, and Alzheimer's disease: a review. Microsc Res Tech 50, 287-290. (Pubitemid 30651168)
5. Crisby M, Rahman SM, Sylven C, Winblad B, Schultzberg M (2004) Effects of high cholesterol diet on gliosis in apolipopro-tein E knockout mice. Implications for Alzheimer's disease and stroke. Neurosci Lett 369, 87-92. (Pubitemid 39265406)
6. Reiss AB, Siller KA, Rahman MM, Chan ES, Ghiso J, de Leon MJ (2004) Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol Aging 25, 977-989. (Pubitemid 38798059)
7. Sparks DL (2008) The early and ongoing experience with the cholesterol-fed rabbit as a model of Alzheimer's disease: the old, the new and the pilot. J Alzheimers Dis 15, 641-656.
8. PuglielliL, Tanzi RE, Kovacs DM(2003) Alzheimer's disease: the cholesterol connection. Nat Neurosci 6, 345-351. (Pubitemid 36373979)
9. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA (2009) Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 28, 75-80.
10. Sparks DL, Schreurs BG (2003) Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci U S A 100, 11065-11069. (Pubitemid 37140153)
11. Ghribi O, Golovko MY, Larsen B, Schrag M, Murphy EJ (2006) Deposition of iron and beta-amyloid plaques is associated with corticalcellulardamage inrabbits fed with long-term cholesterol-enriched diets. J Neurochem 99, 438-449. (Pubitemid 44477201)
12. Chen X, Gawryluk JW, Wagener JF, Ghribi O, Geiger JD (2008) Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation 5, 12.
13. Tate BA, Mathews PM (2006) Targeting the role of the endo-some in the pathophysiology of Alzheimer's disease: a strategy for treatment. Sci Aging Knowledge Environ 2006, re2.
14. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci 28, 6926-6937.
15. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA (2004) Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging 25, 1263-1272. (Pubitemid 39299162)
16. Arriagada C, Astorga C, Atwater I, Rojas E, Mears D, Caviedes R, CaviedesP (2007) Endosomalabnormalities relatedtoamy-loid precursor protein in cholesterol treated cerebral cortex neuronal cells derived from trisomy 16 mice, an animal model of Down syndrome. Neurosci Lett 423, 172-177. (Pubitemid 47263547)
17. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hy-man BT, Nixon RA (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 157, 277-286. (Pubitemid 30641743)
18. Cataldo AM, Thayer CY, Bird ED, Wheelock TR, Nixon RA (1990) Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res 513, 181-192. (Pubitemid 20132254)
19. Nixon RA (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120, 4081-4091.
20. Cataldo AM, Hamilton DJ, Nixon RA (1994) Lysosomal abnormalities indegenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 640, 68-80. (Pubitemid 24086532)
21. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
22. Marzolo MP, Bu G (2009) Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease. Semin Cell Dev Biol 20, 191-200.
23. Granholm AC, Bimonte-Nelson HA, Moore AB, Nelson ME, Freeman LR, Sambamurti K (2008) Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis 14, 133-145. (Pubitemid 352040036)
24. Thirumangalakudi L, Prakasam A, Zhang R, Bimonte-Nelson H, Sambamurti K, Kindy MS, Bhat NR (2008) High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem 106, 475-485. (Pubitemid 351840227)
25. Sparks DL, Scheff SW, Hunsaker JC, 3rd, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126, 88-94.
26. Ghribi O, Larsen B, Schrag M, Herman MM (2006) High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 200, 460-467. (Pubitemid 44107924)
27. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 95, 6460-6464. (Pubitemid 28249035)
28. Frears ER, Stephens DJ, Walters CE, Davies H, Austen BM (1999) The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport 10, 1699-1705.
29. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann Ket al. (2001) Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A 98, 5856-5861. (Pubitemid 32435732)
30. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA (2000) Statins and the risk of dementia. Lancet 356, 1627-1631.
31. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57, 1439-1443.
32. Zerbinatti CV, Bu G (2005) LRP and Alzheimer's disease. Rev Neurosci 16, 123-135. (Pubitemid 40806892)
33. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem 262, 14352-14360. (Pubitemid 17152101)
34. Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfac-tion in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 55, 84-90. (Pubitemid 28139109)
35. Peters JM, Hummel T, Kratzsch T, Lotsch J, Skarke C, Frolich L (2003) Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 160, 1995-2002. (Pubitemid 39619637)
36. Doty RL (2009) The olfactory system and its disorders. Semin Neurol 29, 74-81.
37. Kovacs T, Cairns NJ, Lantos PL (2001) Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport 12, 285-288. (Pubitemid 32114366)
38. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC (2001) Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 125, 489-492. (Pubitemid 32291552)
39. Ohyagi Y (2008) Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease. Curr Alzheimer Res 5, 555-561.
40. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120-134. (Pubitemid 32193626)
41. Oyama F, Murakami N, Ihara Y (1998) Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease. Neurosci Res 31, 1-8. (Pubitemid 28325592)
42. Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow EM, Cuervo AM, Mandelkow E (2009) Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet 18, 4153-4170.
43. Hamano T, Gendron TF, Causevic E, Yen SH, Lin WL, Isidoro C, Deture M, Ko LW (2008) Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur J Neurosci 27, 1119-1130. (Pubitemid 351432336)
44. Distl R, Treiber-Held S, Albert F,Meske V, Harzer K, Ohm TG (2003) Cholesterol storage and taupathology in Niemann-Pick type C disease in the brain. J Pathol 200, 104-111. (Pubitemid 36592643)
45. Bi X, Liao G (2007) Autophagic-lysosomal dysfunction and neurodegeneration in Niemann-Pick Type C mice: lipid starvation or indigestion? Autophagy 3, 646-648. (Pubitemid 350060071)
46. Liao G, Yao Y, Liu J, Yu Z, Cheung S, Xie A, Liang X, Bi X (2007) Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain. Am J Pathol 171, 962-975. (Pubitemid 47440994)
47. Woodruff-Pak DS, Agelan A, Del Valle L (2007) A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels. J Alzheimers Dis 11, 371-383. (Pubitemid 47094031)
48. Maxfield FR, Tabas I (2005) Role of cholesterol and lipid organization in disease. Nature 438, 612-621. (Pubitemid 41740565)
49. Vance JE, Karten B, Hayashi H (2006) Lipid dynamics in neurons. Biochem Soc Trans 34, 399-403. (Pubitemid 43953997)
50. Sleat DE, Wiseman JA, El-Banna M, Price SM, Verot L, Shen MM, Tint GS, Vanier MT, Walkley SU, Lobel P (2004) Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A 101, 5886-5891. (Pubitemid 38520498)
51. Namba Y, Tsuchiya H, Ikeda K (1992) Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease. Neurosci Lett 134, 264-266.
52. Takechi R, Galloway S, Pallebage-Gamarallage M, Wellington C, Johnsen R, Mamo JC (2009) Three-dimensional colo-calization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice. Histochem Cell Biol 131, 661-666.
53. Nixon RA, Cataldo AM, Mathews PM(2000) Theendosomal-lysosomal system of neurons in Alzheimer's disease patho-genesis: a review. Neurochem Res 25, 1161-1172.
54. Zhang L, Sheng R, Qin Z (2009) The lysosome and neurode-generative diseases. Acta Biochim Biophys Sin (Shanghai) 41, 437-445.
55. Pinching AJ, Powell TP (1971) The neuropil of the periglomerular region of the olfactory bulb. J Cell Sci 9, 379-409.
56. Pinching AJ, Powell TP (1971) The neuropil of the glomeruli of the olfactory bulb. J Cell Sci 9, 347-377.
57. Ressler KJ, Sullivan SL, Buck LB (1994) Information coding in the olfactory system: evidence for a stereotyped and highly organized epitope map in the olfactory bulb. Cell 79, 1245-1255.
58. Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, Larson EB (1999) Impaired olfactionas a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 53, 1480-1487. (Pubitemid 29491941)
59. Gilbert PE, Murphy C (2004) The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls. J Clin Exp Neuropsychol 26, 779-794. (Pubitemid 39362660)
60. Perry G, Castellani RJ, Smith MA, Harris PL, Kubat Z, Ghanbari K, Jones PK, Cordone G, Tabaton M, Wolozin Bet al. (2003) Oxidative damage in the olfactory system in Alzheimer's disease. Acta Neuropathol 106, 552-556. (Pubitemid 37441611)
61. Wesson DW, Wilson DA, Nixon RA (2010) Should olfactory dysfunction be used as a biomarker of Alzheimer's disease? Expert Rev Neurother 10, 633-635.
62. Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han LY, Lee VM, Trojanowski JQ (2010) Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 67, 462-469.
63. Kovacs T, Cairns NJ, Lantos PL (1999) beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neuro-biol 25, 481-491. (Pubitemid 30045422)
64. Thomann PA, Dos Santos V, Seidl U, Toro P, Essig M, Schroder J (2009) MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 17, 213-221.
65. Thomann PA, Dos Santos V, Toro P, Schonknecht P, Essig M, Schroder J (2009) Reduced olfactory bulb and tract volume in early Alzheimer's disease-a MRI study. Neurobiol Aging 30, 838-841.
66. Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008) Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies. Acta Neuropathol 116, 17-24.
67. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791. (Pubitemid 35231524)
68. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
69. Spires-Jones TL, Meyer-Luehmann M, Osetek JD, Jones PB, Stern EA, Bacskai BJ, Hyman BT (2007) Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. Am J Pathol 171, 1304-1311. (Pubitemid 47582903)
70. Dong H, Martin MV, Chambers S, Csernansky JG (2007) Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J Comp Neurol 500, 311-321. (Pubitemid 44937125)
71. Rutten BP, Van der Kolk NM, Schafer S, van Zandvoort MA, Bayer TA, Steinbusch HW, Schmitz C (2005) Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice. Am J Pathol 167, 161-173. (Pubitemid 40884779)
72. Murthy VN, Stevens CF (1998) Synaptic vesicles retain their identity through the endocytic cycle. Nature 392, 497-501. (Pubitemid 28168981)
73. Kuromi H, Kidokoro Y (1998) Two distinct pools of synap-tic vesicles in single presynaptic boutons in a temperature-sensitive Drosophila mutant, shibire. Neuron 20, 917-925. (Pubitemid 28247397)
74. Blumstein J, Faundez V, Nakatsu F, Saito T, Ohno H, Kelly RB (2001) The neuronal form of adaptor protein-3 is required for synaptic vesicle formation from endosomes. J Neurosci 21, 8034-8042. (Pubitemid 32952760)
75. Callahan LM, Vaules WA, Coleman PD (1999) Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol 58, 275-287. (Pubitemid 29140968)
76. Bahr BA, Bendiske J (2002) The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83, 481-489. (Pubitemid 35231802)
77. Bendiske J, Bahr BA (2003) Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis-an approach for slowing Alzheimer disease? J Neuropathol Exp Neurol 62, 451-463. (Pubitemid 36560187)
78. Bendiske J, Caba E, Brown QB, Bahr BA (2002) Intracellular deposition, microtubule destabilization, and transport failure: an "early" pathogenic cascade leading to synaptic decline. J Neuropathol Exp Neurol 61, 640-650. (Pubitemid 34721469)
79. Kanju PM, Parameshwaran K, Vaithianathan T, Sims CM, Huggins K, Bendiske J, Ryzhikov S, Bahr BA, Sup-piramaniam V (2007) Lysosomal dysfunction produces distinct alterations in synaptic alpha-amino-3-hydroxy-5- methylisoxazolepropionic acid and N-methyl-D-aspartate receptor currents in hippocampus. J Neuropathol Exp Neurol 66, 779-788. (Pubitemid 47360953)
80. Ferreira A, Caceres A, Kosik KS (1993) Intraneuronal compartments of the amyloid precursor protein. J Neurosci 13, 3112-3123. (Pubitemid 23199236)
81. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, Chen X, Stokin GB, Koo EH (1999) Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 274, 18851-18856.
82. Soriano S, Chyung AS, Chen X, Stokin GB, Lee VM, Koo EH (1999) Expression of beta-amyloid precursor protein-CD3gamma chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments. J Biol Chem 274, 32295-32300.
83. Chyung JH, Selkoe DJ (2003) Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J Biol Chem 278, 51035-51043. (Pubitemid 38020337)
84. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff Ret al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
85. Shimizu H, Tosaki A, Kaneko K, Hisano T, Sakurai T, Nukina N (2008) Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production. Mol Cell Biol 28, 3663-3671. (Pubitemid 351732903)
86. Rajendran L, Schneider A, Schlechtingen G, Weidlich S, Ries J, Braxmeier T, Schwille P, Schulz JB, Schroeder C, Simons Met al. (2008) Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Science 320, 520-523. (Pubitemid 351590663)
87. Jin LW, Shie FS, Maezawa I, Vincent I, Bird T (2004) Intracel- lular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am J Pathol 164, 975-985. (Pubitemid 38235479)
88. Waldron E, Jaeger S, Pietrzik CU (2006) Functional role of the low-density lipoprotein receptor-related protein in Alzheimer's disease. Neurodegener Dis 3, 233-238. (Pubitemid 44600309)
89. Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH (2002) The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. Embo J 21, 5691-5700. (Pubitemid 35315269)
90. Pietrzik CU, Yoon IS, Jaeger S, Busse T, Weggen S, Koo EH (2004) FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci 24, 4259-4265. (Pubitemid 38620802)
91. Bu G, Cam J, Zerbinatti C (2006) LRP in amyloid-beta production and metabolism. Ann N Y Acad Sci 1086, 35-53.
92. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Hyman BT, Strickland DK (1995) LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82, 331-340.
93. Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, Strickland DK (2000) Modulationofbeta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem 275, 7410-7415. (Pubitemid 30146296)
94. Koh YH, von Arnim CA, Hyman BT, Tanzi RE, Tesco G (2005) BACE is degraded via the lysosomal pathway. J Biol Chem 280, 32499-32504. (Pubitemid 41361863)
95. Higaki J, Catalano R, Guzzetta AW, Quon D, Nave JF, Tarnus C, D'Orchymont H, Cordell B (1996) Processing of beta-amyloid precursor protein by cathepsin D. J Biol Chem 271, 31885-31893. (Pubitemid 26422210)
96. Saftig P, Peters C, von Figura K, Craessaerts K, Van Leuven F, De Strooper B (1996) Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem 271, 27241-27244. (Pubitemid 26367274)
97. Ladror US, Snyder SW, Wang GT, Holzman TF, Krafft GA (1994) Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J Biol Chem 269, 18422-18428. (Pubitemid 24224073)
98. Hamazaki H (1996) Cathepsin D is involved in the clearance of Alzheimer's beta-amyloid protein. FEBS Lett 396, 139-142. (Pubitemid 26377812)